Global OTC Anti-Infective Medications Supply, Demand and Key Producers, 2023-2029

Page: 107

Published Date: 21 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global OTC Anti-Infective Medications market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global OTC Anti-Infective Medications demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for OTC Anti-Infective Medications, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of OTC Anti-Infective Medications that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global OTC Anti-Infective Medications total market, 2018-2029, (USD Million)
Global OTC Anti-Infective Medications total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: OTC Anti-Infective Medications total market, key domestic companies and share, (USD Million)
Global OTC Anti-Infective Medications revenue by player and market share 2018-2023, (USD Million)
Global OTC Anti-Infective Medications total market by Type, CAGR, 2018-2029, (USD Million)
Global OTC Anti-Infective Medications total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global OTC Anti-Infective Medications market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline, Merck, Pfizer, Novartis, Abbott, Sanofi, Bristol-Myers Squibb, Roche and NanoViricides, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World OTC Anti-Infective Medications market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global OTC Anti-Infective Medications Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global OTC Anti-Infective Medications Market, Segmentation by Type
    Antifungals
    Antiseptic
    Antiparasitics

Global OTC Anti-Infective Medications Market, Segmentation by Application
    Hospital Pharmacies
    Drug Stores
    E-Commerce

Companies Profiled:
    GlaxoSmithKline
    Merck
    Pfizer
    Novartis
    Abbott
    Sanofi
    Bristol-Myers Squibb
    Roche
    NanoViricides
    Novabay Pharmaceuticals
    Optimer Pharmaceuticals
    Basilea Pharmaceutica
    MerLion Pharma

Key Questions Answered
1. How big is the global OTC Anti-Infective Medications market?
2. What is the demand of the global OTC Anti-Infective Medications market?
3. What is the year over year growth of the global OTC Anti-Infective Medications market?
4. What is the total value of the global OTC Anti-Infective Medications market?
5. Who are the major players in the global OTC Anti-Infective Medications market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 OTC Anti-Infective Medications Introduction
    1.2 World OTC Anti-Infective Medications Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World OTC Anti-Infective Medications Total Market by Region (by Headquarter Location)
        1.3.1 World OTC Anti-Infective Medications Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States OTC Anti-Infective Medications Market Size (2018-2029)
        1.3.3 China OTC Anti-Infective Medications Market Size (2018-2029)
        1.3.4 Europe OTC Anti-Infective Medications Market Size (2018-2029)
        1.3.5 Japan OTC Anti-Infective Medications Market Size (2018-2029)
        1.3.6 South Korea OTC Anti-Infective Medications Market Size (2018-2029)
        1.3.7 ASEAN OTC Anti-Infective Medications Market Size (2018-2029)
        1.3.8 India OTC Anti-Infective Medications Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 OTC Anti-Infective Medications Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 OTC Anti-Infective Medications Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World OTC Anti-Infective Medications Consumption Value (2018-2029)
    2.2 World OTC Anti-Infective Medications Consumption Value by Region
        2.2.1 World OTC Anti-Infective Medications Consumption Value by Region (2018-2023)
        2.2.2 World OTC Anti-Infective Medications Consumption Value Forecast by Region (2024-2029)
    2.3 United States OTC Anti-Infective Medications Consumption Value (2018-2029)
    2.4 China OTC Anti-Infective Medications Consumption Value (2018-2029)
    2.5 Europe OTC Anti-Infective Medications Consumption Value (2018-2029)
    2.6 Japan OTC Anti-Infective Medications Consumption Value (2018-2029)
    2.7 South Korea OTC Anti-Infective Medications Consumption Value (2018-2029)
    2.8 ASEAN OTC Anti-Infective Medications Consumption Value (2018-2029)
    2.9 India OTC Anti-Infective Medications Consumption Value (2018-2029)

3 World OTC Anti-Infective Medications Companies Competitive Analysis
    3.1 World OTC Anti-Infective Medications Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global OTC Anti-Infective Medications Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for OTC Anti-Infective Medications in 2022
        3.2.3 Global Concentration Ratios (CR8) for OTC Anti-Infective Medications in 2022
    3.3 OTC Anti-Infective Medications Company Evaluation Quadrant
    3.4 OTC Anti-Infective Medications Market: Overall Company Footprint Analysis
        3.4.1 OTC Anti-Infective Medications Market: Region Footprint
        3.4.2 OTC Anti-Infective Medications Market: Company Product Type Footprint
        3.4.3 OTC Anti-Infective Medications Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: OTC Anti-Infective Medications Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: OTC Anti-Infective Medications Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: OTC Anti-Infective Medications Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: OTC Anti-Infective Medications Consumption Value Comparison
        4.2.1 United States VS China: OTC Anti-Infective Medications Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: OTC Anti-Infective Medications Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based OTC Anti-Infective Medications Companies and Market Share, 2018-2023
        4.3.1 United States Based OTC Anti-Infective Medications Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies OTC Anti-Infective Medications Revenue, (2018-2023)
    4.4 China Based Companies OTC Anti-Infective Medications Revenue and Market Share, 2018-2023
        4.4.1 China Based OTC Anti-Infective Medications Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies OTC Anti-Infective Medications Revenue, (2018-2023)
    4.5 Rest of World Based OTC Anti-Infective Medications Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based OTC Anti-Infective Medications Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies OTC Anti-Infective Medications Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World OTC Anti-Infective Medications Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Antifungals
        5.2.2 Antiseptic
        5.2.3 Antiparasitics
    5.3 Market Segment by Type
        5.3.1 World OTC Anti-Infective Medications Market Size by Type (2018-2023)
        5.3.2 World OTC Anti-Infective Medications Market Size by Type (2024-2029)
        5.3.3 World OTC Anti-Infective Medications Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World OTC Anti-Infective Medications Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital Pharmacies
        6.2.2 Drug Stores
        6.2.3 E-Commerce
    6.3 Market Segment by Application
        6.3.1 World OTC Anti-Infective Medications Market Size by Application (2018-2023)
        6.3.2 World OTC Anti-Infective Medications Market Size by Application (2024-2029)
        6.3.3 World OTC Anti-Infective Medications Market Size by Application (2018-2029)

7 Company Profiles
    7.1 GlaxoSmithKline
        7.1.1 GlaxoSmithKline Details
        7.1.2 GlaxoSmithKline Major Business
        7.1.3 GlaxoSmithKline OTC Anti-Infective Medications Product and Services
        7.1.4 GlaxoSmithKline OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 GlaxoSmithKline Recent Developments/Updates
        7.1.6 GlaxoSmithKline Competitive Strengths & Weaknesses
    7.2 Merck
        7.2.1 Merck Details
        7.2.2 Merck Major Business
        7.2.3 Merck OTC Anti-Infective Medications Product and Services
        7.2.4 Merck OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Merck Recent Developments/Updates
        7.2.6 Merck Competitive Strengths & Weaknesses
    7.3 Pfizer
        7.3.1 Pfizer Details
        7.3.2 Pfizer Major Business
        7.3.3 Pfizer OTC Anti-Infective Medications Product and Services
        7.3.4 Pfizer OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Pfizer Recent Developments/Updates
        7.3.6 Pfizer Competitive Strengths & Weaknesses
    7.4 Novartis
        7.4.1 Novartis Details
        7.4.2 Novartis Major Business
        7.4.3 Novartis OTC Anti-Infective Medications Product and Services
        7.4.4 Novartis OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Novartis Recent Developments/Updates
        7.4.6 Novartis Competitive Strengths & Weaknesses
    7.5 Abbott
        7.5.1 Abbott Details
        7.5.2 Abbott Major Business
        7.5.3 Abbott OTC Anti-Infective Medications Product and Services
        7.5.4 Abbott OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Abbott Recent Developments/Updates
        7.5.6 Abbott Competitive Strengths & Weaknesses
    7.6 Sanofi
        7.6.1 Sanofi Details
        7.6.2 Sanofi Major Business
        7.6.3 Sanofi OTC Anti-Infective Medications Product and Services
        7.6.4 Sanofi OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Sanofi Recent Developments/Updates
        7.6.6 Sanofi Competitive Strengths & Weaknesses
    7.7 Bristol-Myers Squibb
        7.7.1 Bristol-Myers Squibb Details
        7.7.2 Bristol-Myers Squibb Major Business
        7.7.3 Bristol-Myers Squibb OTC Anti-Infective Medications Product and Services
        7.7.4 Bristol-Myers Squibb OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Bristol-Myers Squibb Recent Developments/Updates
        7.7.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
    7.8 Roche
        7.8.1 Roche Details
        7.8.2 Roche Major Business
        7.8.3 Roche OTC Anti-Infective Medications Product and Services
        7.8.4 Roche OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Roche Recent Developments/Updates
        7.8.6 Roche Competitive Strengths & Weaknesses
    7.9 NanoViricides
        7.9.1 NanoViricides Details
        7.9.2 NanoViricides Major Business
        7.9.3 NanoViricides OTC Anti-Infective Medications Product and Services
        7.9.4 NanoViricides OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 NanoViricides Recent Developments/Updates
        7.9.6 NanoViricides Competitive Strengths & Weaknesses
    7.10 Novabay Pharmaceuticals
        7.10.1 Novabay Pharmaceuticals Details
        7.10.2 Novabay Pharmaceuticals Major Business
        7.10.3 Novabay Pharmaceuticals OTC Anti-Infective Medications Product and Services
        7.10.4 Novabay Pharmaceuticals OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Novabay Pharmaceuticals Recent Developments/Updates
        7.10.6 Novabay Pharmaceuticals Competitive Strengths & Weaknesses
    7.11 Optimer Pharmaceuticals
        7.11.1 Optimer Pharmaceuticals Details
        7.11.2 Optimer Pharmaceuticals Major Business
        7.11.3 Optimer Pharmaceuticals OTC Anti-Infective Medications Product and Services
        7.11.4 Optimer Pharmaceuticals OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Optimer Pharmaceuticals Recent Developments/Updates
        7.11.6 Optimer Pharmaceuticals Competitive Strengths & Weaknesses
    7.12 Basilea Pharmaceutica
        7.12.1 Basilea Pharmaceutica Details
        7.12.2 Basilea Pharmaceutica Major Business
        7.12.3 Basilea Pharmaceutica OTC Anti-Infective Medications Product and Services
        7.12.4 Basilea Pharmaceutica OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Basilea Pharmaceutica Recent Developments/Updates
        7.12.6 Basilea Pharmaceutica Competitive Strengths & Weaknesses
    7.13 MerLion Pharma
        7.13.1 MerLion Pharma Details
        7.13.2 MerLion Pharma Major Business
        7.13.3 MerLion Pharma OTC Anti-Infective Medications Product and Services
        7.13.4 MerLion Pharma OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 MerLion Pharma Recent Developments/Updates
        7.13.6 MerLion Pharma Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 OTC Anti-Infective Medications Industry Chain
    8.2 OTC Anti-Infective Medications Upstream Analysis
    8.3 OTC Anti-Infective Medications Midstream Analysis
    8.4 OTC Anti-Infective Medications Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World OTC Anti-Infective Medications Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World OTC Anti-Infective Medications Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World OTC Anti-Infective Medications Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World OTC Anti-Infective Medications Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World OTC Anti-Infective Medications Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World OTC Anti-Infective Medications Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World OTC Anti-Infective Medications Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World OTC Anti-Infective Medications Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World OTC Anti-Infective Medications Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key OTC Anti-Infective Medications Players in 2022
    Table 12. World OTC Anti-Infective Medications Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global OTC Anti-Infective Medications Company Evaluation Quadrant
    Table 14. Head Office of Key OTC Anti-Infective Medications Player
    Table 15. OTC Anti-Infective Medications Market: Company Product Type Footprint
    Table 16. OTC Anti-Infective Medications Market: Company Product Application Footprint
    Table 17. OTC Anti-Infective Medications Mergers & Acquisitions Activity
    Table 18. United States VS China OTC Anti-Infective Medications Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China OTC Anti-Infective Medications Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based OTC Anti-Infective Medications Companies, Headquarters (States, Country)
    Table 21. United States Based Companies OTC Anti-Infective Medications Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies OTC Anti-Infective Medications Revenue Market Share (2018-2023)
    Table 23. China Based OTC Anti-Infective Medications Companies, Headquarters (Province, Country)
    Table 24. China Based Companies OTC Anti-Infective Medications Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies OTC Anti-Infective Medications Revenue Market Share (2018-2023)
    Table 26. Rest of World Based OTC Anti-Infective Medications Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies OTC Anti-Infective Medications Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies OTC Anti-Infective Medications Revenue Market Share (2018-2023)
    Table 29. World OTC Anti-Infective Medications Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World OTC Anti-Infective Medications Market Size by Type (2018-2023) & (USD Million)
    Table 31. World OTC Anti-Infective Medications Market Size by Type (2024-2029) & (USD Million)
    Table 32. World OTC Anti-Infective Medications Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World OTC Anti-Infective Medications Market Size by Application (2018-2023) & (USD Million)
    Table 34. World OTC Anti-Infective Medications Market Size by Application (2024-2029) & (USD Million)
    Table 35. GlaxoSmithKline Basic Information, Area Served and Competitors
    Table 36. GlaxoSmithKline Major Business
    Table 37. GlaxoSmithKline OTC Anti-Infective Medications Product and Services
    Table 38. GlaxoSmithKline OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. GlaxoSmithKline Recent Developments/Updates
    Table 40. GlaxoSmithKline Competitive Strengths & Weaknesses
    Table 41. Merck Basic Information, Area Served and Competitors
    Table 42. Merck Major Business
    Table 43. Merck OTC Anti-Infective Medications Product and Services
    Table 44. Merck OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Merck Recent Developments/Updates
    Table 46. Merck Competitive Strengths & Weaknesses
    Table 47. Pfizer Basic Information, Area Served and Competitors
    Table 48. Pfizer Major Business
    Table 49. Pfizer OTC Anti-Infective Medications Product and Services
    Table 50. Pfizer OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Pfizer Recent Developments/Updates
    Table 52. Pfizer Competitive Strengths & Weaknesses
    Table 53. Novartis Basic Information, Area Served and Competitors
    Table 54. Novartis Major Business
    Table 55. Novartis OTC Anti-Infective Medications Product and Services
    Table 56. Novartis OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Novartis Recent Developments/Updates
    Table 58. Novartis Competitive Strengths & Weaknesses
    Table 59. Abbott Basic Information, Area Served and Competitors
    Table 60. Abbott Major Business
    Table 61. Abbott OTC Anti-Infective Medications Product and Services
    Table 62. Abbott OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Abbott Recent Developments/Updates
    Table 64. Abbott Competitive Strengths & Weaknesses
    Table 65. Sanofi Basic Information, Area Served and Competitors
    Table 66. Sanofi Major Business
    Table 67. Sanofi OTC Anti-Infective Medications Product and Services
    Table 68. Sanofi OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Sanofi Recent Developments/Updates
    Table 70. Sanofi Competitive Strengths & Weaknesses
    Table 71. Bristol-Myers Squibb Basic Information, Area Served and Competitors
    Table 72. Bristol-Myers Squibb Major Business
    Table 73. Bristol-Myers Squibb OTC Anti-Infective Medications Product and Services
    Table 74. Bristol-Myers Squibb OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Bristol-Myers Squibb Recent Developments/Updates
    Table 76. Bristol-Myers Squibb Competitive Strengths & Weaknesses
    Table 77. Roche Basic Information, Area Served and Competitors
    Table 78. Roche Major Business
    Table 79. Roche OTC Anti-Infective Medications Product and Services
    Table 80. Roche OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Roche Recent Developments/Updates
    Table 82. Roche Competitive Strengths & Weaknesses
    Table 83. NanoViricides Basic Information, Area Served and Competitors
    Table 84. NanoViricides Major Business
    Table 85. NanoViricides OTC Anti-Infective Medications Product and Services
    Table 86. NanoViricides OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. NanoViricides Recent Developments/Updates
    Table 88. NanoViricides Competitive Strengths & Weaknesses
    Table 89. Novabay Pharmaceuticals Basic Information, Area Served and Competitors
    Table 90. Novabay Pharmaceuticals Major Business
    Table 91. Novabay Pharmaceuticals OTC Anti-Infective Medications Product and Services
    Table 92. Novabay Pharmaceuticals OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Novabay Pharmaceuticals Recent Developments/Updates
    Table 94. Novabay Pharmaceuticals Competitive Strengths & Weaknesses
    Table 95. Optimer Pharmaceuticals Basic Information, Area Served and Competitors
    Table 96. Optimer Pharmaceuticals Major Business
    Table 97. Optimer Pharmaceuticals OTC Anti-Infective Medications Product and Services
    Table 98. Optimer Pharmaceuticals OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Optimer Pharmaceuticals Recent Developments/Updates
    Table 100. Optimer Pharmaceuticals Competitive Strengths & Weaknesses
    Table 101. Basilea Pharmaceutica Basic Information, Area Served and Competitors
    Table 102. Basilea Pharmaceutica Major Business
    Table 103. Basilea Pharmaceutica OTC Anti-Infective Medications Product and Services
    Table 104. Basilea Pharmaceutica OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Basilea Pharmaceutica Recent Developments/Updates
    Table 106. MerLion Pharma Basic Information, Area Served and Competitors
    Table 107. MerLion Pharma Major Business
    Table 108. MerLion Pharma OTC Anti-Infective Medications Product and Services
    Table 109. MerLion Pharma OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 110. Global Key Players of OTC Anti-Infective Medications Upstream (Raw Materials)
    Table 111. OTC Anti-Infective Medications Typical Customers
List of Figure
    Figure 1. OTC Anti-Infective Medications Picture
    Figure 2. World OTC Anti-Infective Medications Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World OTC Anti-Infective Medications Total Market Size (2018-2029) & (USD Million)
    Figure 4. World OTC Anti-Infective Medications Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World OTC Anti-Infective Medications Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company OTC Anti-Infective Medications Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company OTC Anti-Infective Medications Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company OTC Anti-Infective Medications Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company OTC Anti-Infective Medications Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company OTC Anti-Infective Medications Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company OTC Anti-Infective Medications Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company OTC Anti-Infective Medications Revenue (2018-2029) & (USD Million)
    Figure 13. OTC Anti-Infective Medications Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World OTC Anti-Infective Medications Consumption Value (2018-2029) & (USD Million)
    Figure 16. World OTC Anti-Infective Medications Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States OTC Anti-Infective Medications Consumption Value (2018-2029) & (USD Million)
    Figure 18. China OTC Anti-Infective Medications Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe OTC Anti-Infective Medications Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan OTC Anti-Infective Medications Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea OTC Anti-Infective Medications Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN OTC Anti-Infective Medications Consumption Value (2018-2029) & (USD Million)
    Figure 23. India OTC Anti-Infective Medications Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of OTC Anti-Infective Medications by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for OTC Anti-Infective Medications Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for OTC Anti-Infective Medications Markets in 2022
    Figure 27. United States VS China: OTC Anti-Infective Medications Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: OTC Anti-Infective Medications Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World OTC Anti-Infective Medications Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World OTC Anti-Infective Medications Market Size Market Share by Type in 2022
    Figure 31. Antifungals
    Figure 32. Antiseptic
    Figure 33. Antiparasitics
    Figure 34. World OTC Anti-Infective Medications Market Size Market Share by Type (2018-2029)
    Figure 35. World OTC Anti-Infective Medications Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 36. World OTC Anti-Infective Medications Market Size Market Share by Application in 2022
    Figure 37. Hospital Pharmacies
    Figure 38. Drug Stores
    Figure 39. E-Commerce
    Figure 40. OTC Anti-Infective Medications Industrial Chain
    Figure 41. Methodology
    Figure 42. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

GlaxoSmithKline
Merck
Pfizer
Novartis
Abbott
Sanofi
Bristol-Myers Squibb
Roche
NanoViricides
Novabay Pharmaceuticals
Optimer Pharmaceuticals
Basilea Pharmaceutica
MerLion Pharma

Related Reports

Global OTC Anti-Infective Medications Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global OTC Anti-Infective Medications Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 09 Jan 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global OTC Anti-Infective Medications market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global OTC Anti-Infective Medications Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global OTC Anti-Infective Medications Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global OTC Anti-Infective Medications market size was valued at USD 87960 million in 2023 and is forecast to a readjusted size of USD 122780 million by 2030 with a CAGR of 4.9% during review period.

Product Tags

OTC Anti-Infective Medications

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>